1Yamazaki T, Kume H, Yamashita E, et al. Epidemiology of visceral mycoses: analysis on data in′Annual of the Pathological Autopsy Cases in Japan′(Abstract P-117)[A]. In: 13th Congress of the International Society for Human and Animal Mycology (Parma, Italy), 1997.
2Lortholary O, Ascioglu S, Moreau P, et al. Invasive aspe-rgillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the Intergroup Francais du Myelome[J]. Clin Infect Dis, 2000, 30(1): 41-46.
4Kleinschmidt-DeMasters BK. Central nervous system aspe-rgillosis: a 20-year retrospective series[J]. Hum Pathol, 2002, 33(1): 116.
5Mylonakis E, Paliou M, Sax PE, et al. Central nervous system aspergillosis in patients with human immunodeficiency virus infection. Report of 6 cases and review[J]. Br J Neurosurg, 2000, 14(2): 137-141.
7Lin S J, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature[J]. Clin Infect Dis, 2001, 32(3): 358-366.
8Hagensee ME, Bauwens JE, Kjos B, et al. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992[J]. Clin Infect Dis, 1994, 19: 402-408.
9Janssen JJ, Strack-van-Schijindel RJ, van-der-Poest-Clement EH, et al. Outcome of ICU treatment in invasive aspergillosis[J]. Intensive Care Med, 1996, 22(12): 1315-1322.
10Kami M, Ogawa S, Kanda Y. Early diagnosis of central nervous system aspergillosis using polymerase chain reaction, latex agglutination test, and enzyme-linked immunosorbent assay[J]. Br J Haematol, 1999, 106(2): 536-537.
6Mattiuzzi G, Giles FJ. Management of intraeranial fungal infections in patients with haematologieal malignancies. Br J Haematol, 2005, 131:287-300.
7Kim DG, Hong SC, Kim HJ, et al. Cerebral aspergillosis in immunologically competent patients. Surg Neurol, 1993, 40: 326-331.
8Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. Medicine (Baltimore), 2000, 79:250-260.
9Sanchez C, Mauri E, Dalmau D, et al. Treatment of cerebral aspergillosis with itraconazole:do high doses improve the prognosis? Clin Infect Dis, 1995, 21:1485-1487.
10Bohme A, Ruhnke M, Buchheidt D, et al. Treatment of fungal infections in hematology and oncology. Ann Hematol, 2003, 82:S133-140.
